Ms. Yasheika Pink Brown, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 5051 W Avenue M4, Quartz Hill, CA 93536 Phone: 323-978-3624 |
Che'ron Deyvonne Brown, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 42263 50th St W, Quartz Hill, CA 93536 Phone: 951-269-5814 |
News Archive
The September issue of the online scientific journal Acta Crystallographica: Structural Biology and Crystallization Communications (Acta Cryst F) will consist entirely of work done at the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory.
BioTime, Inc. today announced a material transfer agreement (MTA) with the University of California (UC) system to make five research-grade human embryonic stem (hES) cell lines available to UC system researchers. These lines are genetically identical to a bank of GMP-compliant hES cell lines that will be made available to California-based researchers under a recent agreement between BioTime and the California Institute for Regenerative Medicine (CIRM).
In the first of a series titled "Imagine a world...," posted on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Paula Franklin, U.K. medical director for Marie Stopes International, writes, "For the most part, only people who really need or want something care much about it being available, and that's why it can be hard to make people in the developed world tune in to the huge unmet need for contraception globally - 222 million people who want to use contraception can't get it, at the last count."
Virginia Attorney General Ken Cuccinelli says he is taking on the IRS over a Medicaid fraud settlement payment from which the state is owed $125 million.
Onyx Pharmaceuticals, Inc. today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.
› Verified 2 days ago